Mobic meloxicam
Refer to the “Also Known As” section to reference different products that include the same medication as Mobic.
Drug Basics
Brand Name: Mobic
Generic Name: MELOXICAM
Drug Type: HUMAN PRESCRIPTION DRUG
Route: ORAL
Dosage Form: TABLET
Data Current As Of: 2019-05-20
indications & usage
osteoarthritis (oa)
MOBIC is indicated for reliefof the signs and symptoms of osteoarthritis [see ClinicalStudies (14.1)].
rheumatoid arthritis (ra)
MOBIC is indicated for relief of the signsand symptoms of rheumatoid arthritis [see Clinical Studies(14.1)].
juvenile rheumatoidarthritis (jra) pauciarticular & polyarticular course
MOBIC isindicated for relief of the signs and symptoms of pauciarticular orpolyarticular course Juvenile Rheumatoid Arthritis in patients whoweigh ≥60 kg [see Dosage and Administration (2.4) and Clinical Studies (14.2)].
patient counseling information
Advise the patient to read the FDA-approvedpatient labeling (Medication Guide) that accompanies each prescriptiondispensed.
Informpatients, families or their caregivers of the following informationbefore initiating therapy with an NSAID and periodically during thecourse of ongoing therapy.
Cardiovascular Thrombotic Events
Advise patientsto be alert for the symptoms of cardiovascular thrombotic events,including chest pain, shortness of breath, weakness, or slurring ofspeech, and to report any of these symptoms to their healthcare providerimmediately [see Warnings and Precautions (5.1)].
Gastrointestinal Bleeding, Ulceration,and Perforation
Advise patients to report symptoms of ulcerationsand bleeding, including epigastric pain, dyspepsia, melena, and hematemesisto their healthcare provider. In the setting of concomitant use oflow-dose aspirin for cardiac prophylaxis, inform patients of the increasedrisk for the signs and symptoms of GI bleeding [see Warningsand Precautions (5.2)].
Hepatotoxicity
Inform patientsof the warning signs and symptoms of hepatotoxicity (e.g., nausea,fatigue, lethargy, diarrhea, pruritus, jaundice, right upper quadranttenderness, and "flu‑like" symptoms). If these occur, instruct patientsto stop MOBIC and seek immediate medical therapy [see Warningsand Precautions (5.3)].
Heart Failure andEdema
Advise patients to be alert for the symptoms of congestive heartfailure including shortness of breath, unexplained weight gain, oredema and to contact their healthcare provider if such symptoms occur[see Warnings and Precautions (5.5)].
Anaphylactic Reactions
Inform patients of the signs of an anaphylacticreaction (e.g., difficulty breathing, swelling of the face or throat).Instruct patients to seek immediate emergency help if these occur[see Contraindications (4)and Warnings and Precautions (5.7)].
Serious Skin Reactions
Advise patients to stop MOBIC immediatelyif they develop any type of rash and to contact their healthcare provideras soon as possible [see Warnings and Precautions (5.9)].
Female Fertility
Advise females of reproductivepotential who desire pregnancy that NSAIDs, including MOBIC, may beassociated with a reversible delay in ovulation [see Use inSpecific Populations (8.3)].
FetalToxicity
Inform pregnant women to avoid use of MOBIC and other NSAIDs startingat 30 weeks gestation because of the risk of the premature closingof the fetal ductus arteriosus [see Warnings and Precautions(5.10) and Use in Specific Populations(8.1)].
Avoid Concomitant Use of NSAIDs
Inform patientsthat the concomitant use of MOBIC with other NSAIDs or salicylates(e.g., diflunisal, salsalate) is not recommended due to the increasedrisk of gastrointestinal toxicity, and little or no increase in efficacy[see Warnings and Precautions (5.2) and Drug Interactions (7)]. Alert patients that NSAIDs may be present in “over the counter”medications for treatment of colds, fever, or insomnia.
Use of NSAIDs andLow-Dose Aspirin
Inform patients not to use low-dose aspirinconcomitantly with MOBIC until they talk to their healthcare provider[see Drug Interactions (7)].
For current prescribinginformation, scan the code below or call Boehringer Ingelheim Pharmaceuticals,Inc. at 1-800-542-6257 or TTY 1-800-459-9906.
Distributed by: BoehringerIngelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
Licensed from: Boehringer IngelheimInternational GmbH
Copyright 2016 Boehringer Ingelheim International GmbH
ALL RIGHTS RESERVED
090340141/11
OT1407KF302016
This Medication Guide has been approved by the U.S. Food and DrugAdministration. | Revised: May 2016 |
Medication Guide for Nonsteroidal Anti-inflammatory Drugs (NSAIDs) | |
What is themost important information I should know about medicines called NonsteroidalAnti-inflammatory Drugs (NSAIDs)? NSAIDs cancause serious side effects, including:
| |
What are NSAIDs? NSAIDs are used to treat pain and redness, swelling,and heat (inflammation) from medical conditions such as differenttypes of arthritis, menstrual cramps, and other types of short-termpain. | |
Who shouldnot take NSAIDs? Do not take NSAIDs:
| |
Before takingNSAIDs, tell your healthcare provider about all of your medical conditions,including if you:
Tell your healthcare provider about all of the medicinesyou take, including prescription or over-the-counter medicines, vitaminsor herbal supplements. NSAIDs and some other medicines caninteract with each other and cause serious side effects. Donot start taking any new medicine without talking to your healthcareprovider first. | |
What are thepossible side effects of NSAIDs? NSAIDs cancause serious side effects, including: See“What is the most important information I should know about medicinescalled Nonsteroidal Anti-inflammatory Drugs (NSAIDs)?”
Get emergency help right away if you get any of the followingsymptoms:
Stop taking your NSAID and call your healthcare providerright away if you get any of the following symptoms:
If you take too much of your NSAID, call your healthcareprovider or get medical help right away. | |
Other informationabout NSAIDs:
| |
General informationabout the safe and effective use of NSAIDs If you would like more information about NSAIDs, talk with yourhealthcare provider. You can ask your pharmacist or healthcare providerfor information about NSAIDs that is written for health professionals. | |
Distributed by:Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT 06877 USA Licensed from: Boehringer Ingelheim International GmbH Boehringer Ingelheim Pharmaceuticals, Inc. either ownsor uses the trademark Mobic® under license. The other trademarks referencedare owned by third parties not affiliated with Boehringer IngelheimPharmaceuticals, Inc. Copyright 2016 BoehringerIngelheim International GmbH 090340141/11 |
Mobic® (meloxicam) Tablets Label
7.5 mg/100 Tablets
NDC: 0597002901
Mobic® (meloxicam) Tablets Label
15 mg/100 Tablets
NDC: 0597003001